Vulcabras S.A.
1. Earnings Analysis — Last Four Quarters
Anchoring verification. The most recently published quarterly result for Vulcabras at the time of this report is 1Q26 (quarter ended March 31, 2026), released on May 5, 2026, containing confirmed reported figures for net revenue, gross profit, EBITDA, and net income — not analyst estimates. A cross-check against the company's most recent earnings calendar confirms no subsequent quarter has been published. The four-quarter coverage sequence is therefore: 1Q26 → 4Q25 → 3Q25 → 2Q25, a continuous run with no gaps.
1.1 Quarter-by-Quarter Snapshot
1.2 Beat / Miss Detail
Sell-side consensus for Vulcabras is thin relative to large-cap names: Bloomberg-aggregated consensus figures were only consistently reported for the bottom line in 1Q26 and 4Q25. Revenue consensus figures were not located in public sources for any of the four quarters under review and are marked accordingly. Where consensus is unavailable, the table reports the reported actual and YoY change only.
| Quarter | Net Revenue (Actual) | Revenue vs. Consensus | Net Income (Recurring) | NI vs. Consensus | Sports Footwear Revenue | Stock Reaction (report day) |
|---|---|---|---|---|---|---|
| 2Q25 | R$ 894.8M | N/D | R$ 353.3M (unadjusted) | N/D | (dados não localizados) | Not specifically reported |
| 3Q25 | R$ 955.7M | N/D | R$ 163.0M (recurring) | N/D | (dados não localizados) | Flat — closed unchanged at R$ 22.14 |
| 4Q25 | R$ 1,000.0M | N/D | R$ 158.8M | BEAT — R$ 158.8M vs. R$ 152M (Bloomberg) | +11.2% category growth | +2.7% close, intraday +6% |
| 1Q26 | R$ 776.4M | N/D | R$ 80.1M (reported) / R$ 86.1M (recurring) | MISS — R$ 80.1M vs. R$ 82M (Bloomberg) | R$ 653.2M, +11.3% YoY | Shares advanced on results day |
1.3 Revenue & Margin Trajectory
| Metric | 2Q25 | 3Q25 | 4Q25 | 1Q26 |
|---|---|---|---|---|
| Net Revenue | R$ 894.8M | R$ 955.7M | R$ 1,000.0M | R$ 776.4M |
| Revenue YoY Growth | +17.6% | +21.8% | +11.4% | +10.7% |
| Gross Profit | (dados não localizados) | (dados não localizados) | ~R$ 414M (41.4% margin) | R$ 313.5M |
| Gross Margin | (dados não localizados) | (dados não localizados) | 41.4% | 40.4% |
| Recurring EBITDA | R$ 296.4M* | R$ 211.0M | R$ 220.7M | R$ 156.9M |
| Recurring EBITDA Margin | ~33.1%* | 22.1% | 21.9% | 20.2% |
| Recurring Net Income | (dados não localizados) | R$ 163.0M | R$ 158.8M | R$ 86.1M |
| Net Debt (period-end) | (dados não localizados) | (dados não localizados) | R$ 769.4M | R$ 658.9M |
| Net Debt / EBITDA | (dados não localizados) | (dados não localizados) | 0.9x | 0.7x |
1.4 Quarter-Defining Events
Vulcabras opened the second quarter of fiscal 2025 with the first visible sign of an unusually large jump in profitability — net income up 152.9% YoY to R$353.3 million and EBITDA up 69% to R$296.4 million, against "only" 17.6% revenue growth. The disproportionate bottom-line move pre-dated the deferred-tax recognition that would dominate the following quarter's headlines and coincided with the early stages of a balance-sheet restructuring that management would later use to fund an extraordinary dividend program. Operationally, the quarter continued the company's now-familiar pattern: double-digit revenue growth led by sports footwear, with Olympikus's running franchise as the standout performer.
The third quarter delivered the fastest revenue growth of the four-quarter window (+21.8% YoY, to R$955.7 million) and crossed R$1.1 billion in gross operating revenue for the first time in a single quarter — the company's 21st consecutive quarter of growth. The headline, however, was dominated by a one-off: the recognition of more than R$366 million in deferred tax assets pushed unadjusted net income to roughly R$547 million, nearly triple the prior-year figure, even as the cleaner recurring net income figure (R$163 million, +11.6% YoY) showed a much more modest — though still healthy — improvement. The quarter also marked an inflection in capital allocation: the board approved R$597.6 million in extraordinary dividends alongside a private capital increase of up to R$597.7 million, setting the stage for a sharp rise in financial leverage entering 2026.
The fourth quarter closed out a record fiscal year with the company's first-ever R$1 billion net revenue quarter (+11.4% YoY), its 22nd consecutive quarter of growth. Recurring net income of R$158.8 million beat the Bloomberg-aggregated consensus of R$152 million by roughly 4.5%, and shares jumped as much as 6% intraday before settling up 2.7% on the day. Sell-side reaction was constructive but cautious: BTG Pactual called the print "encouraging," while XP Investimentos characterized results as "mixed," flagging a deceleration in revenue growth (from +22% in 3Q25 to +11% in 4Q25) against a backdrop of an unusually promotional retail environment with early Black Friday discounting. For the full year, Vulcabras posted record gross revenue of R$4.2 billion (+16.7%), net revenue of R$3.56 billion (+16.8%), recurring EBITDA of R$763.1 million (+13.0%, 21.4% margin) and recurring net income of R$572.9 million (+5.3%, 16.1% net margin) — alongside R$1.54 billion in total 2025 dividend distributions.
The first quarter of 2026 extended the growth streak to 23 consecutive quarters, with record first-quarter net revenue of R$776.4 million (+10.7% YoY), driven once again by the sports footwear category (+11.3% to R$653.2 million, on volume growth of +10.5% to 4.8 million pairs). Operationally the quarter was solid — recurring EBITDA rose 11.8% to R$156.9 million with a slight margin improvement to 20.2%, and gross margin held near 40.4%. But the headline net income figures disappointed: reported net income fell 24.5% YoY to R$80.1 million (a 2.3% miss against the R$82 million Bloomberg consensus), and recurring net income fell 18.9% to R$86.1 million. The culprit was financial expenses — Vulcabras swung from a R$2.3 million net financial gain in 1Q25 to a R$27.8 million net financial loss in 1Q26, a direct consequence of the higher debt load taken on in late 2025 to fund working capital, capex and the extraordinary dividend program. Encouragingly, net debt fell 14.4% sequentially to R$658.9 million (0.7x EBITDA), and the company generated R$156 million of cash in the quarter, suggesting the deleveraging process announced by management is already underway. The quarter also included a R$6 million non-recurring charge related to the write-off of discontinued e-commerce software.
1.5 Recurring Earnings Patterns
- 01. The revenue growth streak (23 consecutive quarters as of 1Q26) has been sustained primarily by price/mix improvements and premiumization rather than pure volume expansion — 1Q26 volume grew 6.8% while revenue grew 10.7%, and management has explicitly chosen to prioritize margin over volume in a promotional retail environment.
- 02. Recurring EBITDA margin has compressed steadily across the four-quarter window — from an apparent ~33% in 2Q25 (likely inflated by one-offs) to 22.1% (3Q25), 21.9% (4Q25) and 20.2% (1Q26) — reflecting the cumulative impact of higher payroll costs from the company's industrial workforce expansion.
- 03. Headline net income has become increasingly decoupled from recurring net income due to large non-operating items: a R$366M+ deferred tax credit in 3Q25 and a R$6M software write-off in 1Q26 are the most recent examples, requiring careful reconciliation each quarter.
- 04. The net financial result has flipped from a net gain (R$2.3M in 1Q25) to a net loss (R$27.8M in 1Q26), directly tracking the rise in net debt from a low base to R$769.4M at year-end 2025, itself a consequence of the R$1.54bn in 2025 dividend distributions.
- 05. Sports footwear — anchored by Olympikus's "Corre" running franchise and supplemented by the licensed Mizuno and Under Armour brands — remains the dominant growth engine in every quarter reviewed, consistently outpacing apparel and accessories.
1.6 Key Metrics the Market Monitors
| KPI | Latest Reading (1Q26) | Signal Threshold |
|---|---|---|
| Net revenue YoY growth | +10.7% | Sustained >10% supports the consecutive-growth-streak narrative; deceleration below high-single digits would be the first break in over five years |
| Recurring EBITDA margin | 20.2% | A move below ~20% would signal the labor-cost pressure cycle has not yet inflected, as BTG/XP both flagged |
| Gross margin | 40.4% | Stability near 40–41% is the floor management has defended through three consecutive quarters |
| Net debt / EBITDA | 0.7x | A continued sequential decline toward ~0.5x or below would validate the deleveraging thesis |
| Net financial result | -R$27.8M | A narrowing of the net financial expense would be the clearest signal of successful deleveraging and a direct tailwind to recurring net income |
| E-commerce share of revenue | 15.3% (FY25) | Continued growth (+25% YoY in FY25) supports the DTC margin-mix thesis |
| Sports footwear volume growth | +10.5% (1Q26) | The primary leading indicator for the category that drives ~84% of net revenue |
1.7 What to Watch — Next Earnings (2Q26)
Based on the historical reporting cadence (2Q25 results were released in early August 2025), 2Q26 results are expected to be published in early August 2026.
Net financial result trend: a sequential narrowing from the -R$27.8M posted in 1Q26 would confirm that the deleveraging from R$769.4M to R$658.9M in net debt is translating into lower interest expense and a recovery in recurring net income growth.
Gross margin trajectory: three consecutive quarters near 40–41% suggest a plateau; whether labor-cost pressure from the 2024–2025 hiring cycle has fully normalized will determine if margins can re-expand toward the ~41.4% level seen in 4Q25.
Revenue growth deceleration: the YoY growth rate has stepped down in three consecutive quarters (21.8% → 11.4% → 10.7%); a further deceleration toward high single digits would break the "accelerating growth" framing that has supported the valuation re-rating narrative from BTG and others.
Dividend policy for 2026: management has guided toward a normalized dividend yield near 8.2% for 2026, sharply below the 32.4% TTM figure inflated by 2025's extraordinary distributions. Confirmation (or further cuts) to this guidance will be closely watched by the income-oriented shareholder base.
M&A commentary: CEO Pedro Bartelle has signaled that "there's room for more brands" in the portfolio and that the company is mapping acquisition opportunities, contingent on lower benchmark interest rates in Brazil. Any concrete announcement would be a structural positive for the long-term growth thesis.
US tariff-driven reshoring: following the announcement of US tariffs in 2025, Under Armour's global team contacted Vulcabras to assess shifting Asian production volume to its Ceará facility — a potential structural volume tailwind for the Under Armour license that bears monitoring for concrete order commitments.
2. Institutional Analysis
2.1 Business Model & Revenue Architecture
Vulcabras is Brazil's largest manager of sporting-goods brands, operating a vertically integrated manufacturing model across two factories in Horizonte (Ceará) and Itapetinga (Bahia), with a distribution center in Extrema (Minas Gerais), a technology and development center in Parobé (Rio Grande do Sul), and an administrative headquarters in Jundiaí (São Paulo). The group employs more than 17,000 people and distributes through more than 19,000 points of sale in Brazil and across 15+ countries, with the strongest international presence in Latin America (Peru and Chile).
The company's brand architecture rests on three pillars: Olympikus, its own brand and Brazil's national leader in running footwear, particularly through its "Corre" performance line (including the world's first graphene-plate running shoe); Under Armour, operated under an exclusive Brazilian license signed in 2018; and Mizuno, whose Brazilian operations and license were acquired from Alpargatas in 2021 for R$32.5 million. Sports footwear is by far the largest category, representing roughly 84% of 1Q26 net revenue (R$653.2M of R$776.4M), with apparel and accessories making up the remainder.
| Component | FY2025 Figure | Commentary |
|---|---|---|
| Net Revenue | R$ 3.56bn | +16.8% YoY, 22nd consecutive quarter of growth achieved in 4Q25 |
| Gross Revenue (faturamento bruto) | R$ 4.2bn | Record, +16.7% YoY |
| Recurring EBITDA | R$ 763.1M | 21.4% margin, +13.0% YoY |
| Recurring Net Income | R$ 572.9M | 16.1% net margin, +5.3% YoY |
| E-commerce Revenue | R$ 543.1M | +25.0% YoY; 15.3% of net revenue |
| Net Debt (year-end) | R$ 769.4M | 0.9x EBITDA leverage |
| Total Dividends Distributed | R$ 1,541.9M | Driven by tax-reform-related restructuring; not expected to recur at this scale |
2.2 Competitive Moat Assessment
| Pillar | Strength | Risk | PGS Rating |
|---|---|---|---|
| Multi-brand portfolio (Olympikus + licensed Under Armour & Mizuno) | High — gives Vulcabras exposure across price points and consumer segments not achievable with a single brand | License renewal/termination risk for Under Armour and Mizuno is structural and outside management's full control | ★★★★★ |
| Vertically integrated manufacturing (Ceará & Bahia plants) | High — enables rapid product-mix shifts and cost/efficiency capture that pure distributors lack | Labor cost inflation in domestic manufacturing has been the primary margin headwind across all four quarters reviewed | ★★★★★ |
| Distribution network breadth (19,000+ points of sale, 15+ countries) | Medium-high — broad multibrand retail penetration in Brazil provides resilient reach | Heavy reliance on multibrand retail exposes the company to promotional/discounting cycles, as seen in 4Q25 | ★★★★★ |
| Direct-to-consumer / e-commerce momentum | Medium — growing fast (+25% in FY25) and reaching 15.3% of revenue, with margin-accretive potential | Still a minority of revenue; a R$6M software write-off in 1Q26 shows execution is not friction-free | ★★★★★ |
| Product technology / brand equity (Olympikus "Corre", graphene-plate running line) | Medium-high — supports price/mix gains that have outpaced volume growth for several consecutive quarters | Global performance-running technology cycles (carbon/graphene plates) are intensely competitive and require continuous R&D investment | ★★★★★ |
2.3 Top 3 Risks
Brand License Concentration
High Severity · Medium-TermTwo of Vulcabras's three core brands — Under Armour and Mizuno — are operated under license agreements with foreign principals rather than owned outright. While both relationships currently appear constructive (Under Armour's global team reportedly approached Vulcabras about reshoring Asian production following US tariff changes, and the Mizuno license has been in place since 2021), license agreements are inherently time-limited and subject to renegotiation or termination outside the company's full control. Given that sports footwear represents roughly 84% of net revenue and that Olympikus alone would not replicate the combined scale of the current three-brand portfolio, any deterioration in either licensing relationship would represent a structural — not merely cyclical — risk to the long-term revenue base. Management's stated intent to pursue additional brand acquisitions (its only owned-brand addition since 2021) can be read as a partial hedge against this concentration.
Gross & EBITDA Margin Compression from Labor Costs
Medium Severity · Near-TermRecurring EBITDA margin has declined in three consecutive quarters for which comparable data is available — from 22.1% (3Q25) to 21.9% (4Q25) to 20.2% (1Q26) — a pattern both BTG Pactual and XP Investimentos have attributed to the cumulative effect of workforce expansion at Vulcabras's domestic manufacturing plants undertaken during the 2024–2025 growth cycle. XP specifically characterized the gross margin pressure as "near an inflection point" as of the 4Q25 print, but 1Q26's 40.4% gross margin (down slightly from 41.4% in 4Q25) suggests the inflection has not yet fully materialized. If labor-cost normalization is delayed further into 2026, recurring earnings growth — already negative YoY in the two most recent quarters — could remain under pressure even as top-line growth persists.
Leverage-Driven Financial Expense Following the 2025 Capital Restructuring
Medium Severity · Near-Term to Medium-TermThe R$1.54 billion in dividends distributed during 2025 — funded in part by new debt — pushed net debt from a comparatively low base to R$769.4 million at year-end 2025 (0.9x EBITDA), and the resulting net financial result swung from a R$2.3 million gain in 1Q25 to a R$27.8 million loss in 1Q26. This single line item was the primary driver of the 18.9% YoY decline in recurring net income in 1Q26 despite an 11.8% increase in recurring EBITDA. While net debt already fell 14.4% sequentially in 1Q26 (to R$658.9 million, 0.7x EBITDA) and the company generated R$156 million of cash in the quarter — both encouraging signs — the pace of deleveraging and the trajectory of Brazilian benchmark interest rates will jointly determine how quickly this drag on recurring earnings dissipates.
2.4 Long-Term Growth Architecture
| Driver | Timeline | Current State | Potential | Status |
|---|---|---|---|---|
| E-commerce / DTC expansion | 1–3 years | 15.3% of FY25 net revenue (R$543.1M), +25% YoY; ~20 owned stores (mostly Under Armour/Mizuno) | Margin-accretive channel mix shift; DTC penetration in developed sportswear markets often exceeds 25–30% | On Track |
| Premiumization via performance running technology | Ongoing | Olympikus "Corre Turbo," "Supra," and graphene-plate running shoes driving price/mix gains; volume +6.8% vs. revenue +10.7% in 1Q26 | Continued price/mix outperformance vs. volume supports margin defense even in a promotional retail environment | On Track |
| Brand portfolio expansion via M&A | 2–4 years | CEO has stated the company is "mapping opportunities" and that "there's room for more brands," contingent on lower domestic interest rates | The 2021 Mizuno acquisition (R$32.5M) demonstrates a template for accretive, capital-light brand additions to an existing distribution and manufacturing base | Early Stage |
| US tariff-driven manufacturing reshoring (Under Armour) | 1–2 years | Under Armour's global team contacted Vulcabras in May 2025 to evaluate shifting Asian production volume to the Ceará facility | Incremental contract-manufacturing volume for a global brand would be a structural, multi-year revenue tailwind for the licensed Under Armour operation | Early Stage |
| Latin American geographic expansion | 2–5 years | Present in 15+ countries with ~50 stores in Peru and franchise operations in Chile; international presence remains a minority of revenue | Replicating the Brazilian multibrand-distribution playbook regionally could diversify the revenue base away from Brazilian consumer-cycle dependence | Early Stage |
| Deleveraging post extraordinary 2025 dividend | 1–2 years | Net debt fell from R$769.4M (0.9x EBITDA) to R$658.9M (0.7x EBITDA) in a single quarter, with R$156M of 1Q26 cash generation | A return to a near-net-cash position would eliminate the financial-expense drag that compressed 1Q26 recurring net income | On Track |
2.5 Bull Case vs. Bear Case
🟢 Bull Case
- Core Assumptions
- Revenue growth stabilizes in the 10–15% YoY range as the growth-streak narrative continues; gross margin re-expands toward the 41–41.4% levels seen in 4Q25 as the 2024–2025 labor-cost cycle fully normalizes; net financial expense narrows materially as deleveraging continues toward sub-0.5x EBITDA; recurring net income re-accelerates back to double-digit YoY growth by late 2026.
- Implied FY26 Revenue
- ~R$ 3.9–4.0bn (+10–12% YoY)
- Implied FY26 Recurring Net Income
- Return toward FY25 levels (~R$ 570–620M) as financial expense drag fades
- 18–24 Month Price Target
- R$ 22 – 24
- Requirements for This Scenario
- Sequential net debt reduction continues for at least 2–3 more quarters; gross margin stabilizes or improves; no disruption to the Under Armour or Mizuno license agreements; the Under Armour reshoring discussion converts into incremental contract volume.
🔴 Bear Case
- Core Assumptions
- Revenue growth continues its three-quarter deceleration trend (21.8% → 11.4% → 10.7%) toward high single digits or lower as the promotional retail environment persists; gross margin fails to re-inflect from the ~40% level, keeping recurring EBITDA margin pinned near or below 20%; deleveraging stalls and net financial expense remains a persistent drag on recurring net income; the 2026 dividend yield normalizes sharply to the ~8.2% level guided by management, disappointing the income-oriented shareholder base that drove much of the stock's prior re-rating.
- Implied FY26 Revenue
- ~R$ 3.7–3.8bn (+4–7% YoY)
- Implied FY26 Recurring Net Income
- Roughly flat to down vs. FY25 (~R$ 500–570M) as margin and financial-expense pressures persist
- Downside Reference
- R$ 10 – 11 (a de-rating toward ~1.3x P/BV, near the lower end of the stock's recent multiple band, vs. the current 1.89x)
- Triggers for This Scenario
- A fourth consecutive quarter of declining recurring net income; gross margin breaking below 40%; any signal of friction in the Under Armour or Mizuno license relationships; a 2026 dividend cut beyond the already-guided normalization.
Note: an independent DCF-based fair value estimate from SimplyWall.st (based on a panel of 6 analysts) places intrinsic value at approximately R$6.83 per share — substantially below both the current price (R$14.80) and the bear-case downside reference above. This divergence likely reflects DCF models' sensitivity to the recent volatility in free cash flow and dividend distributions, and is presented here as a data point for context rather than as a price target.
2.6 Valuation Context
| Metric | Current | Forward Estimate | Historical Range / Commentary |
|---|---|---|---|
| P/E (TTM) | 4.15x | ~8x (2026E, per BTG Pactual) | The TTM figure is depressed by the unusually large 3Q25 net income (boosted by R$366M+ in deferred tax recognition); the ~8x forward 2026E figure cited by BTG is the more representative comparable |
| P/BV (Price-to-Book) | 1.89x | (dados não localizados) | Implies a book value per share of approximately R$7.83 at the current price of R$14.80 |
| EV/EBITDA (TTM, computed) | ~7.3x | (dados não localizados) | Computed as (Market Cap R$5.0bn + Net Debt R$658.9M) ÷ TTM Recurring EBITDA of ~R$779.7M (FY25 R$763.1M − 1Q25 R$140.3M + 1Q26 R$156.9M) |
| Dividend Yield (TTM) | 32.4% | ~8.2% (2026E, company guidance) | The TTM figure reflects the R$1.54bn extraordinary distribution program executed in 2025 and is explicitly flagged by management as non-recurring; the 8.2% 2026E guidance is the relevant comparable for ongoing valuation |
| Net Debt / EBITDA | 0.7x | (dados não localizados) | Down from 0.9x at year-end 2025; management has signaled continued deleveraging as a priority |
2.7 Analyst Landscape
Constructive / Buy
BTG Pactual — maintains an "outperform" (buy-equivalent) rating, citing the stock's ~8x 2026E P/E, one of the highest dividend yields in the bank's coverage universe, robust top-line expansion, and a more favorable long-term outlook tied to the Under Armour and Mizuno brand agreements following the 4Q25 print.
Mixed / Cautious
XP Investimentos — characterized 4Q25 results as "mixed," noting a clear deceleration in revenue growth from +22% (3Q25) to +11% (4Q25) and gross margin pressure from recent hiring, describing the latter as "near an inflection point" but not yet resolved as of 1Q26.
Valuation Caution
A DCF-based intrinsic value estimate aggregated from a panel of 6 analysts (via SimplyWall.st) places fair value materially below the current share price, flagging the stock as overvalued on a discounted-cash-flow basis even as price-target-based commentary from local Brazilian brokerages (citing targets of R$22–24) implies substantial upside from current levels — a notable divergence in methodology and conclusion that warrants monitoring as 2026 cash flows normalize.
Sell-side coverage of VULC3 is concentrated among Brazilian domestic brokerages and banks (BTG Pactual, XP Investimentos) rather than global bulge-bracket research, consistent with the stock's mid-cap, domestically-focused profile (market capitalization of approximately R$5.0 billion). Price-target commentary referencing a R$22–24 range (implying 40–52% upside from a reference price near R$15.70) was attributed to unnamed Brazilian brokerage analysts in financial press coverage and could not be independently attributed to a named analyst or firm beyond the general characterization provided.
PGS Verdict
VULC3 currently trades near its 52-week low of R$14.80, down sharply from levels above R$19.90 at the start of 2026 and from a recent high of R$22.14 in October 2025 — a roughly 26–33% decline that has compressed the TTM P/E to 4.15x and pushed the trailing dividend yield to an eye-catching 32.4%. Both of these headline figures are materially distorted by one-time items: the TTM earnings figure is inflated by 3Q25's R$366 million deferred tax recognition, and the trailing dividend yield reflects the R$1.54 billion extraordinary distribution program executed during 2025 that management has explicitly characterized as non-recurring. On a cleaner basis — BTG's cited ~8x 2026E P/E and the company's own ~8.2% 2026E dividend yield guidance — the valuation discount narrows considerably, though it remains low relative to the stock's own growth profile and the 40–52% upside implied by the R$22–24 price-target range referenced in Brazilian financial press.
On fundamentals, Vulcabras remains a high-quality operating story: 23 consecutive quarters of revenue growth, a vertically integrated manufacturing base that supports rapid product-mix shifts, and a three-brand portfolio (Olympikus, Under Armour, Mizuno) with genuine momentum in the sports footwear category, which grew 11.3% YoY in 1Q26 on the strength of Olympikus's premium "Corre" running line. The company crossed R$1 billion in quarterly revenue for the first time in 4Q25 and posted a record fiscal 2025 across nearly every headline metric. E-commerce, while still a minority of revenue at 15.3%, is growing at 25% annually and represents a structurally margin-accretive channel shift that is still in early stages.
The primary risk acknowledgement centers on the disconnect that has opened up between operational performance and recurring earnings over the two most recent quarters. Recurring net income fell 6.1% YoY in 4Q25 and 18.9% YoY in 1Q26 — not because the underlying business deteriorated (recurring EBITDA actually grew 14.8% and 11.8% respectively in those quarters), but because of a financial-expense swing driven by the leverage taken on to fund the 2025 dividend program, compounded by a steady erosion in EBITDA margin (from 22.1% to 20.2% across the four quarters reviewed) attributed by both BTG and XP to labor-cost pressure from the company's recent manufacturing workforce expansion. Until both of these trends visibly reverse — net debt continuing its sequential decline from the current 0.7x EBITDA, and gross margin stabilizing or recovering from 40.4% — recurring earnings growth is likely to remain under pressure even if top-line growth persists in the low double digits.
Near-term catalysts to monitor include the 2Q26 results release (expected early August 2026), where the trajectory of the net financial result and gross margin will be the key swing factors for the recurring earnings narrative; further clarity on 2026 dividend policy following the guided normalization to an ~8.2% yield; any concrete developments on the Under Armour manufacturing-reshoring discussion that emerged in response to 2025 US tariff changes, which could represent an incremental volume tailwind for the licensed Under Armour operation; and any signal of progress on management's stated interest in expanding the brand portfolio through M&A, which would represent the first such transaction since the 2021 Mizuno acquisition and could meaningfully extend the long-term growth runway beyond the current three-brand structure.
Disclaimer
This report has been produced exclusively for the internal use of Polaris Global Strategies Ltd. (PGS), a company incorporated in the British Virgin Islands (BVI), operating as a private vehicle for investment research and analysis on behalf of its partners. This document does not constitute an investment recommendation for any third party, whether individuals or legal entities, and must not be interpreted as such. PGS does not provide asset management, advisory or investment consulting services to any external client, has no client base, and offers no products or services to third parties. Any eventual access to this document by unauthorised parties does not confer validity as investment advice or recommendation. The information and analysis contained herein are based on public sources considered reliable, but PGS makes no warranty as to their completeness or accuracy. Investments in variable income instruments involve risks, including the possibility of total loss of invested capital. The opinions expressed reflect internal analytical judgement as of the publication date and are subject to change without notice.